🇺🇸 FDA
Patent

US 11041202

Method of identifying human compatible T cell receptors specific for an antigenic target

granted A61KA61K2239/28A61K40/11

Quick answer

US patent 11041202 (Method of identifying human compatible T cell receptors specific for an antigenic target) held by Adaptive Biotechnologies Corporation expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Adaptive Biotechnologies Corporation
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2239/28, A61K40/11, A61K40/32, A61K40/4243